315203-39-5

基本信息
1-(2,6-二氯芐基)-3-吡咯烷-1-甲基-1H-吲唑-6-胺
1-(2,6-二氯芐基)-3-(吡咯烷-1-基甲基)-1H-吲唑-6-胺
1-(2,6-DICHLORO-BENZYL)-3-PYRROLIDIN-1-YLMETHYL-1H-INDAZOL-6-YLAMINE
1-[(2,6-dichlorophenyl)methyl]-3-(pyrrolidin-1-ylmethyl)indazol-6-amine
1-[(2,6-dichlorophenyl)methyl]-3-(1-pyrrolidinylmethyl)-1H-indazol-6-amine
1H-Indazol-6-amine,1-[(2,6-dichlorophenyl)methyl]-3-(1-pyrrolidinylmethyl)-
1-[(2,6-dichlorophenyl)methyl]-3-[(pyrrolidin-1-yl)methyl]-1H-indazol-6-amine
物理化學(xué)性質(zhì)
制備方法
![1-[(2,6-dichlorophenyl)methyl]-6-nitro-3-(pyrrolidin-1-ylmethyl)indazole](/CAS/20180529/GIF/372963-38-7.gif)
372963-38-7

315203-39-5
向裝有攪拌子的烘箱干燥的壓力管中加入1-(2,6-二氯芐基)-1H-吲唑-6-胺(18 mg,0.044 mmol)和甲醇(5 mL)。隨后加入六水合三氯化鐵(25 mol%,2.6 mg)、65%一水合肼溶液(0.05 mL,0.7 mmol)及活性炭(20 mg),密封反應(yīng)管,于100℃下攪拌反應(yīng)2小時(shí)。反應(yīng)過程中,取少量反應(yīng)液,減壓濃縮后溶于最小量的高效液相色譜級乙腈中,進(jìn)行LC-MS分析以監(jiān)測反應(yīng)進(jìn)度。反應(yīng)完成后,過濾反應(yīng)混合物,用甲醇(10 mL)洗滌活性炭及濾餅,合并濾液并減壓濃縮,得到粗產(chǎn)物。將粗產(chǎn)物與硅膠混合干燥后,上樣至5 g硅膠柱,采用快速柱色譜法(0-20%甲醇/二氯甲烷梯度洗脫)進(jìn)行純化,得到目標(biāo)化合物1-(2,6-二氯芐基)-3-(吡咯烷-1-基甲基)-1H-吲唑-6-胺(11.5 mg,收率69%),為白色固體。LC-MS保留時(shí)間tR = 1.44 min(方法A);質(zhì)譜m/z = 374.95([M+H]+);1H NMR(300 MHz,CDCl3)δ = 7.57(d,J = 8.5 Hz,1H),7.37(d,J = 8.2 Hz,2H),7.31-7.20(s,1H),6.63(d,J = 8.8 Hz,1H),6.58(s,1H),5.63(s,2H),4.29(s,2H),3.96(br.s.,2H),3.13(br.s.,4H),1.84(br.s.,4H);13C NMR(75 MHz,CDCl3)δ = 146.5,142.5,137.0,131.6,130.3,128.8,121.0,117.7,113.7,92.2,52.3,48.5,48.2,23.9。
參考文獻(xiàn):
[1] Bioorganic and Medicinal Chemistry, 2018, vol. 26, # 9, p. 2514 - 2529
[2] Journal of Medicinal Chemistry, 2001, vol. 44, # 7, p. 1021 - 1024